中国医学创新Issue(27):63-65,3.DOI:10.3969/j.issn.1674-4985.2014.27.021
降钙素原早期诊断乳腺癌化疗后粒细胞减少伴感染的研究
Research of Procalcitonin in Early Diagnosis of Infection in Breast Cancer Patients with Neutropenia after Chemotherapy
郭满 1张浩 1李伟汉 1刘平贤 1杜新峰 1翟晓健1
作者信息
- 1. 河南省南阳市中心医院 河南 南阳 473003
- 折叠
摘要
Abstract
Objective:To explore clinical value of procalcitonin in breast cancer patients with neutropenia associated with fever after chemotherapy. Method:The clinical data of 118 hospitalized patients with breast cancer associated with fever after chemotherapy from March 2008 to September 2012 were analyzed. The patients were divided into the infected group and the fever reasons unknown group according to clinical symptoms,signs,etiology. The relationship of serum procalcitonin levels were comparative analyzed between the two groups. The relationship of serum procalcitonin levels with age,chemotherapy scheme,heating degree and agranulocytosis levels were analyzed. Result:Serum procalcitonin levels in the infected group was significantly higher than the fever reasons unknown group(P<0.05). Serum procalcitonin levels had nothing to do with age,chemotherapy scheme,heating degree and agranulocytosis levels(P>0.05). Conclusion:Serum procalcitonin levels has a great significance for early diagnosis of infection in breast cancer patients with neutropenia associated with fever after chemotherapy,and it did not infected by patients age,chemotherapy scheme, heating degree and agranulocytosis levels.关键词
降钙素原/发热/粒细胞减少Key words
Procalcitonin/Fever/Agranulocytosis引用本文复制引用
郭满,张浩,李伟汉,刘平贤,杜新峰,翟晓健..降钙素原早期诊断乳腺癌化疗后粒细胞减少伴感染的研究[J].中国医学创新,2014,(27):63-65,3.